Sarcoma  >>  National Cancer Institute  >>  Phase 1
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials		 012345678910
            
            
             
allogeneic K562-GM tumor cell vaccine / National Cancer Institute           
          
            
             
7-Hydroxystaurosporine (UCN-01) / National Cancer Institute           
          
            
             
anti-GD2 CAR-T cell therapy / Bellicum, National Cancer Institute           
          
            
             
rhIL-15 / National Cancer Institute